October 14, 2026

New Study Links Medical Conditions to Early-Onset Alzheimer’s Risk

Dr. Jeremy Koppel has explained a new blood test designed to predict Alzheimer’s disease risk by identifying abnormal protein accumulation. This test currently aids in diagnosing individuals who already show symptoms.

A Finnish study proposes that various medical conditions could indicate early-onset Alzheimer’s disease years before diagnosis. The research examined medical records from 407 individuals diagnosed with early-onset Alzheimer’s and 4,035 people without it, focusing on the 15 years leading to diagnosis.

Early Medical Indicators

The study discovered that conditions like depression, vertigo, and headaches were more prevalent in the five years prior to an Alzheimer’s diagnosis. The findings, published in the journal Alzheimer’s & Dementia, highlight significant differences in health conditions between those diagnosed with early-onset Alzheimer’s and those who were not.

Key conditions observed included:

  • Vertigo: 5.9% with diagnosis, 2.1% without
  • Depression: 5.7% with diagnosis, 2.3% without
  • Headache: 4.9% with diagnosis, 1.6% without
  • Stroke: 4.4% with diagnosis, 2.0% without
  • Alcohol-related disorders: 3.4% with diagnosis, 1.4% without
  • Brain disorders: 2.9% with diagnosis, 0.9% without
  • Thyroid disorders: 2.5% with diagnosis, 0.8% without
  • Epilepsy: 2.2% with diagnosis, 0.7% without
  • Delirium: 1.5% with diagnosis, 0.1% without
  • Ear, nose, and throat disorders: 5.2% with diagnosis, 2.9% without

Implications for Diagnosis

The study noted an increase in healthcare visits for early-onset Alzheimer’s patients around the time of diagnosis. This may reflect emerging symptoms. Dr. Suvi-Johanna Krüger highlighted that neuropathological changes begin years before cognitive symptoms appear.

Limitations and Future Research

The research was observational, showing associations but not causation. It cannot confirm whether these medical conditions cause Alzheimer’s or result from it. Further studies may investigate whether genetics, lifestyle, or socioeconomic factors influence outcomes.

Understanding these connections could improve early detection. Larger studies examining biomarkers and clinical assessments might establish causal relationships and enhance diagnostic processes.

Importance of Early Diagnosis

Experts stress the importance of early diagnosis, offering more treatment and support options. Early detection allows families to plan effectively and access necessary support services.

Individuals experiencing symptoms affecting memory or cognition should consult a healthcare provider promptly.

TAGS: